Volume and type of laboratory testing methods for sexually transmitted diseases in public health laboratories, 2007; summary report January 2011
Corporate Authors:National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of STD Prevention. ; Association of Public Health Laboratories (U.S.) ;
Prevention & Control
Sexually Transmitted Diseases
Chlamydia Infections/Prevention & Control
Gonorrhea/Prevention & Control
Sexually Transmitted Diseases/Diagnosis
Sexually Transmitted Diseases/Prevention & Control
Syphilis/Prevention & Control
Description:Executive summary -- Introduction - Methodology -- Results -- Conclusion
This report provides a summary of the responses received from a web-based survey conducted among public health laboratories on the volume and type of testing for sexually transmitted diseases in the United States in 2007. The survey was conducted in January 2008, and responses were received from 61.4% (94 of 153) of all invited participants. Overall in 2007, 3,290,390 chlamydia tests and 3,157,827gonorrhea tests were performed in surveyed laboratories; 89.7% of chlamydia tests and 84.4% of gonorrhea tests were nucleic acid amplification tests (NAATs). Of the 90 labs reporting any gonorrhea testing, 52.1% reported performing gonorrhea culture. Among the surveyed laboratories that reported doing gonorrhea testing, but reported having no culture capacity, 33.3% had access to gonorrhea culture for medical-legal purposes. Over 90% of surveyed laboratories reported conducting syphilis testing. Of the 49 public health laboratories that reported doing herpes testing (79,614 total tests), 71.4% reported doing standard cell culture, and 30.6% of labs performed the HerpesSelect test (type-specific serology). Only 14 labs reported performing any trichomonas testing, and the majority of tests were culture based. Only 10 labs reported performing any bacterial vaginosis testing. Three labs performed 3,315 human papillomavirus tests and 5 labs reported doing pap smears, of which the majority was using liquid-based cytology.
In the United States, about 18.9 million people become infected with one or more sexually transmitted infections each year, often causing severe consequences and adding substantially to healthcare costs. Sexually transmitted diseases (STDs) are one of the most under-recognized health problems. Laboratory technology to detect STDs is ever evolving. To better understand current laboratory test usage and procedures, the Centers for Diseases Control and Prevention, Division of STD Prevention, with assistance from the Association of Public Health Laboratories (APHL), surveyed public health laboratories throughout the U.S. in January 2008. The purpose of the survey was to collect information about the volume and type of testing for STDs in the U.S. in 2007. A similar survey was conducted in February 2005 and in February 2001 (Dicker LW, Mosure DJ, Steece R, Stone KM. Testing for Sexually Transmitted Diseases in U.S. Public Health Laboratories in 2004. Sex Transm Dis 2007;34(1):41-46 and Dicker LW, Mosure DJ, Steece R, Stone KM. Laboratory Tests Used in US Public Health Laboratories for Sexually Transmitted Diseases, 2000. Sex Transm Dis 2004;31(5):259-264). This summary report presents information gathered from the 2007 survey from all the public health laboratories that responded.
Supporting Files:No Additional Files
You May Also Like: